AZN vs STBA · P/E 28, $288.38B cap vs P/E 13, rev $254.4M
AstraZeneca PLC (AZN) versus S&T Bancorp Inc (STBA) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
S&T Bancorp Inc (STBA) is a banks - regional company listed on NASDAQ.
AZN does not have a complete income-statement cache yet.
Latest reported STBA revenue for 2026-06-30 was $254.4M. Net income was $71.7M. STBA currently screens at market cap $1.67B and trailing P/E 13.1.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. STBA currently screens at market cap $1.67B and trailing P/E 13.1.
Not investment advice. Open the AZN and STBA stock pages for the full models.
Not investment advice.